ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CELG Celgene Corporation

108.24
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Celgene Corporation NASDAQ:CELG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 108.24 109.30 109.44 0 01:00:00

Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September

29/08/2016 12:30pm

Business Wire


Celgene (NASDAQ:CELG)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Celgene Charts.

Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences and at an R&D deep dive in September where Celgene management will provide an overview of the Company. The conferences and R&D deep dive will be webcast live and the webcasts will be available in the Investor Relations section of the Company’s website at www.celgene.com.

Wednesday, September 7, 2016, Celgene will present at the Citi 11th Annual Biotech Conference in Boston at 12 noon ET

Monday, September 12, 2016, Celgene will present at the Morgan Stanley Global Healthcare Unplugged Conference in New York City at 2:50 pm ET

Thursday, September 29, 2016, Celgene will webcast an R&D Deep Dive on Protein Homeostasis beginning at 1:30pm ET. The webcast is expected to conclude at 5pm ET.

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com. Follow Celgene on Social Media: @Celgene, Pinterest, LinkedIn, FaceBook and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

Celgene CorporationPatrick E. Flanigan III, (908) 673-9969Corporate VP, Investor RelationsorBrian Gill, (908) 673-9530VP, Corporate Communications

1 Year Celgene Chart

1 Year Celgene Chart

1 Month Celgene Chart

1 Month Celgene Chart

Your Recent History

Delayed Upgrade Clock